Aster DM Healthcare Receives GST Order Demanding Rs 72.91 Lakh from Kochi Commissionerate

Aster DM Healthcare Limited has informed stock exchanges about receiving a GST order from tax authorities, disclosing details under SEBI regulations. The healthcare company received an order from the Assistant Commissioner, Kochi Commissionerate regarding alleged GST violations spanning multiple financial years.

GST Order Details

The order was issued under Section 74 of the Central Goods and Services Tax Act, 2017, and was received by the company on March 25, 2025. The order covers the period from FY 2019-20 to 2023-24 and relates to alleged non-payment of GST on insurance processing fees.

Particulars:	Amount (Rs)
Tax Demand:	36,45,466
Penalty:	36,45,466
Total Demand:	72,90,932

Nature of Alleged Violation

The tax authorities have alleged that the company failed to pay GST on insurance processing fees during the specified period. This has resulted in the issuance of an intimation of amount ascertained as payable under the GST Act, covering both tax liability and penalty components.

Company's Response and Impact Assessment

Aster DM Healthcare has clarified that the GST order will not have any material impact on the company's financial position, operations, or other business activities. The management has emphasized that the order is appealable under the existing legal framework.

The company has indicated its intention to pursue all available legal remedies under GST law to contest the order. This includes the option to file an appeal against the order issued by the Assistant Commissioner.

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company provided comprehensive details as required under SEBI Master Circular and related circulars regarding disclosure of orders received under tax laws.

Authority Details:	Information
Issuing Authority:	Assistant Commissioner, Kochi Commissionerate (Ernakulam Division)
Order Date:	March 25, 2025
Legal Provision:	Section 74, Central GST Act 2017
Coverage Period:	FY 2019-20 to 2023-24

The company has assured stakeholders that it will take necessary actions to address the matter through appropriate legal channels while maintaining its commitment to regulatory compliance.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.30%	+6.87%	+2.35%	+7.18%	+47.79%	+389.77%

Aster DM Healthcare Limited has announced a scheduled meeting with analysts and institutional investors, informing both BSE and NSE stock exchanges in compliance with regulatory requirements.

Meeting Details

The healthcare company has provided specific details about the upcoming investor engagement:

Parameter:	Details
Date:	March 27, 2026
Meeting Type:	Group Meeting
Location:	Bengaluru, Karnataka
Mode:	In Person
Organizer:	ICICI Securities Limited

Regulatory Compliance

The announcement was made pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary and Compliance Officer Hemish Purushottam signed the notification on March 23, 2026.

Important Disclosures

The company has made several key disclosures regarding the meeting:

No unpublished price sensitive information will be shared during the investor meetings
The schedule may undergo changes due to exigencies on the part of investors, analysts, or the company
The meeting is organized by ICICI Securities Limited

Corporate Information

Aster DM Healthcare Limited maintains its registered office in Hyderabad, Telangana, while its corporate office is located in Bengaluru, Karnataka. The company's stock is listed on both BSE and NSE exchanges.

This investor meeting represents part of the company's ongoing engagement with the investment community and analysts, providing a platform for management to interact with stakeholders while maintaining compliance with securities regulations.